ResearcherTheodor Bilharz Research InstituteActive in the last 2 years

Safia Samir

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4121-0448; OpenAlex author ID A5065171913. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Assessing the diagnostic potential of SATB2 and β-catenin as biomarkers and therapeutic targets in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00432-024-06055-z ↗
Urinary biomarkers analysis as a diagnostic tool for early detection of pancreatic adenocarcinoma: Molecular quantification approach. Co-author DOI 10.1016/j.compbiolchem.2024.108171 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Marwa H. A. Hassan · 1 shared paper, 2024 · strength 0.31
- Paper Urinary biomarkers analysis as a diagnostic tool for early detection of pancreatic adenocarcinoma: Molecular quantifica… DOI 10.1016/j.compbiolchem.2024.108171 ↗
Mona Moussa · 1 shared paper, 2025 · strength 0.28
- Paper Assessing the diagnostic potential of SATB2 and β-catenin as biomarkers and therapeutic targets in pancreatic ductal ad… DOI 10.1007/s00432-024-06055-z ↗
Sara Maher · 1 shared paper, 2025 · strength 0.28
- Paper Assessing the diagnostic potential of SATB2 and β-catenin as biomarkers and therapeutic targets in pancreatic ductal ad… DOI 10.1007/s00432-024-06055-z ↗
Noha Said Helal · 1 shared paper, 2025 · strength 0.28
- Paper Assessing the diagnostic potential of SATB2 and β-catenin as biomarkers and therapeutic targets in pancreatic ductal ad… DOI 10.1007/s00432-024-06055-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.